Advances and challenges of CRISPR/Cas gene editing for corneal diseases
This review provides a comprehensive and integrated overview of the current translational directions and challenges of CRISPR/Cas technology in corneal diseases from a novel perspective. It offers valuable guidance for future research and may accelerate the development of gene-editing therapies toward clinical application.
Authors
- Xingchao Shentu
- Ruoqi Chen
- Yuqi Han (ORCID: https://orcid.org/0009-0007-1875-9997)
Institutions
- Shanghai Clinical Research Center (CN)
- Second Affiliated Hospital of Zhejiang University (CN)
Publication Details
- Journal
- Advances in Ophthalmology Practice and Research
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1016/j.aopr.2025.11.002
- Citations
- 1
- Primary Topic
- CRISPR and Genetic Engineering
- Type
- article
- Field-Weighted Citation Impact
- 0.81